Literature DB >> 10881175

Gamma chain required for naïve CD4+ T cell survival but not for antigen proliferation.

O Lantz1, I Grandjean, P Matzinger, J P Di Santo.   

Abstract

Lymphoid homeostasis is required to ensure immune responsiveness and to prevent immunodeficiency. As such, the immune system must maintain distinct populations of naïve T cells that are able to respond to new antigens as well as memory T cells specific to those antigens it has already encountered. Though both naïve and memory T cells reside in and traffic through secondary lymphoid organs, there is growing evidence that the two populations may be regulated differently. We show here that naïve T cell survival and memory T cell survival have different requirements for cytokines (including the interleukins IL-2, IL-4, IL-7, IL-9 and IL-15) that use the common cytokine receptor gamma chain (gamma c). Using monoclonal populations of antigen-specific CD4+ T cells, we found that naïve T cells cannot survive without gamma c, whereas memory T cells show no such requirement. In contrast, neither naïve nor gamma c-deficient memory T cells were impaired in their ability to proliferate and produce cytokines in response to in vivo antigenic stimulation. These data call into question the physiological role of gamma c-dependent cytokines as T cell growth factors and show that naïve and memory CD4+ T cell survival is maintained by distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881175     DOI: 10.1038/76917

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  98 in total

1.  IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells.

Authors:  V Dardalhon; S Jaleco; S Kinet; B Herpers; M Steinberg; C Ferrand; D Froger; C Leveau; P Tiberghien; P Charneau; N Noraz; N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors:  J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 3.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

4.  Resident peritoneal NK cells.

Authors:  Rosemary Gonzaga; Polly Matzinger; Ainhoa Perez-Diez
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

5.  Effects of exogenous IL-2 administration on the homeostasis of CD4+ T lymphocytes.

Authors:  Arnaud Foussat; Laurence Bouchet-Delbos; Jacques Couderc; Dominique Berrebi; Michèle German-Fattal; Marie-Christine Maillot; Ingrid Durand-Gasselin; Pierre Galanaud; James P Di Santo; Dominique Emilie
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

6.  Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire.

Authors:  Booki Min; Gilles Foucras; Martin Meier-Schellersheim; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

Review 7.  The concept of space and competition in immune regulation.

Authors:  Brigitta Stockinger; Thomas Barthlott; George Kassiotis
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

8.  Ten experiments that would make a difference in understanding immune mechanisms.

Authors:  Melvin Cohn
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

9.  Transient modification within a pool of CD4 T cells in the maternal spleen.

Authors:  Elizabeth A Bonney; Michelle T Shepard; Peyman Bizargity
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 10.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.